Potent anti-inflammatory effects of denbinobin mediated by dual inhibition of expression of inducible no synthase and cyclooxygenase 2

Shock

Volumn 35, Issue 2, 2011, Pages 191-197

  Liu, Hsiang Erh ^a   Chang, Anita Shin Yuan ^a   Teng, Che Ming ^a   Chen, Chien Chih ^b   Tsai, An Chi ^a   Yang, Chia Ron ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

COX 2; Denbinobin; dual inhibition of expression; iNOS

Indexed keywords

CD14 ANTIGEN; CYCLOOXYGENASE 2; DENBINOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REPORTER GENE; WESTERN BLOTTING;

ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHRENES; PHOSPHORYLATION; RESPONSE ELEMENTS;

EID: 78751638462     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181f0e9a8     Document Type: Article

References (41)

1. Leung TF, Tang NL, Tang NL, Wong GW, Fok TF: CD14 and toll-like receptors: potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets Inflamm Allergy 4:169-175, 2005.
2. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phyto-chemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480-481:243-268, 2001.
3. Goodwin DC, Landino LM, Marnett LJ: Effects of nitric oxide and nitric oxideY derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. FASEB J 13:1121-1136, 1999.
4. Kim SF, Huri DA, Snyder SH: Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966-1970, 2005.
5. Stoclet JC, Mart́nez MC, Ohlmann P, Chasserot S, Schott C, Kleschyov AL, Schneider F, Andriantsitohaina R: Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 100:107-112, 1999.
6. Varade J, Lamas JR, Fernández-Arquero M, Jover JA, de la Concha EG, Mart́nez A, Fernández-Gutierrez B, Urcelay E: NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis. Nitric Oxide 21:171-174, 2009.
7. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest 93:1095-1101, 1994.
8. Shiraishi Y, Asano K, Niimi K, Fukunaga K, Wakaki M, Kagyo J, Takihara T, Ueda S, Nakajima T, Oguma T, et al.: Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. J Immunol 180:541-549, 2008.
9. Okamoto H, Ito O, Roman RJ, Hudetz AG: Role of inducible nitric oxide syn-thase and cyclooxygenase-2 in endotoxin-induced cerebral hyperemia. Stroke 29:1209-1218, 1998.
10. Lin AW, Chang CC, McCormick CC: Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5¶-flanking region. J Biol Chem 271:11911-11919, 1996.
11. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T: Structure of the human cyclo-oxygenase-2 gene. Biochem J 302:723-727, 1994.
12. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179, 1994.
13. Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-.B activity. Annu Rev Immunol 18:621-663, 2000.
14. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-.B. Annu Rev Cell Biol 10:405-455, 1994.
15. Zhang G, Ghosh S: Toll-like receptor-mediated NF-.B activation: a phyloge-netically conserved paradigm in innate immunity. J Clin Invest 107:13-19, 2001.
16. Geng Y, Zhang B, Lotz M: Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151:6692-6700, 1993.
17. Barnes PJ, Karin M: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997.
18. Jones R, Rubin G, Berenbaum F, Scheiman J: Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Med 121: 464-474, 2008.
19. Sanchez-Duffhues G, Calzado MA, de Vinuesa AG, Appendino G, Fiebich BL, Loock U, Lefarth-Risse A, Krohn K, Munoz E: Denbinobin inhibits nuclear factor-kB and induces apoptosis via reactive oxygen species generation in human leukemic cells. Biochem Pharmacol 77:1401-1409, 2009.
20. Chen HY, Shiao MS, Huang YL, Shen CC, Lin YL, Kuo YH, Chen CC: Anti-oxidant principles from Ephemerantha lonchophylla. J Nat Prod 62:1225-1227, 1999.
21. Chen TH, Pan SL, Guh JH, Chen CC, Huang YT, Pai HC, Teng CM: Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells. Naunyn Schmiedebergs Arch Pharmacol 378:447-457, 2008.
22. Lee YH, Park JD, Back NI, Kim SI, Ahn BZ: In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile. Planta Med 61: 178-180, 1995.
23. Lin TH, Chang SJ, Chen CC, Wang JP, Tsao LT: Two phenanthraquinones from Dendrobium moniliforme. J Nat Prod 64:1084-1086, 2001.
24. Lin YL, Lin JK: (j)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52:465-472, 1997.
25. Kefaloyianni E, Gaitanaki C, Beis I: ERK1/2 and p38-MAPK signaling pathways, through MSK1, are involved in NF-.B transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18:2238-2251, 2006.
26. Kaminska B: MAPK signalling pathways as molecular targets for anti-inflammatory therapyYfrom molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754:253-262, 2005.
27. Yang KC, Uen YH, Suk FM, Liang YC, Wang YJ, Ho YS, Li IH, Lin SY: Molecular mechanisms of denbinobin-induced anti-tumorigenesis effect in colon cancer cells. World J Gastroenterol 11:3040-3045, 2005.
28. Chen CC, Huang YL, Teng CM: Antiplatelet aggregation principles from Ephemerantha lonchophylla. Planta Med 66:372-374, 2000.
29. Yang CR, Guh JH, Teng CM, Chen CC, Chen PH: Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells. Br J Pharmacol 157:1175-1185, 2009.
30. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR: Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114:1666-1672, 1995.
31. Liaudet L, Rosselet A, Schaller MD, Market M, Perret C, Feihl F: Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 177:127-132, 1998.
32. Zhao H, Ma JK, Barger MW, Mercer RR, Millecchia L, Schwegler-Berry D, Castranova V, Ma JY: Reactive oxygen species- and nitric oxideYmediated lung inflammation and mitochondria dysfunction in wild-type and iNOS-deficient mice exposed to diesel exhaust particles. J Toxicol Environ Health A 72:560-570, 2009.
33. Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI: Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin Exp Immunol 155:88-95, 2009.
34. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
35. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D: Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57:217-252, 2005.
36. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 13:85-94, 2001.
37. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912, 2002.
38. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4508, 1994.
39. Kim YJ, Hwang SY, Oh ES, Oh S, Han IO: IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J Neurosci Res 84:1037-1046, 2006.
40. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM: Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414, 1996.
41. Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181, 2010.